Europeans OK expanded use of Amgen’s Blincyto
The European Commission approved an expanded use for Amgen’s leukemia therapy Blincyto in treating pediatric patients Aug. 29. Based on results from a study of 93 pediatric patients, the approval allows its use in patients a year old or older with a particular type of relapsed or refractory acute lymphoblastic leukemia. “Historically, children with relapsed Read More →
Read More →Semtech doubles net income
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Study results modest for Sienna psoriasis treatment
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Business Times announces 2018 40 Under 40 honorees
The Business Times is proud to announce the honorees of the 18th annual 40 Under 40 awards. This year, the Business Times selected some of the region’s top up-and-coming professionals under the age of 40, in an array of industries including finance, professional and other business services, real estate, technology, nonprofits, health care and education. Read More →
Read More →